Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients

NCT01347983 is registered in ClinicalTrials.gov with Chugai Pharma Taiwan as lead sponsor.

NCT NCT01347983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01347983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients
Lead sponsor
Chugai Pharma Taiwan
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2011
Completion date
April 30, 2013
Enrollment
72 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis